In The Loop Banner

The Boon of Liquid Biopsies in Genomic Cancer Care
A Q&A with Pravin J. Mishra, MS, PhD

Cancer is known to be predominantly a genetic disease, and the recent development in next generation sequencing (NGS) technologies has made it possible to not only help patients with a clearer vision of the existing knowledge base, but also in the discovery of new cancer cell mutations. Using NGS in concert with other novel technologies has opened new avenues for more effective cancer therapies. These avenues include the utilization of genomics, epigenomics, proteomics, metabolomics, pharmacogenomics, immunology-based approaches, and other cutting edge technologies, such as genetic editing.

CLICK HERE to read more about the promise of liquid biopsy and NGS as effective tools in the fight against cancer.


Do You Know . . .
That gonorrhea infection remains a public health issue with growing concern?

CLICK HERE to read more about how even though medicinal treatments for gonorrhea (GC) have been widely available for decades, the disease remains quite relevant. Like many pathogens, GC has evolved over the years and has cycled through several stages of therapeutic treatment to the current multi-drug approach. Having witnessed this evolution from what was originally a fairly simple, oral-based drug treatment to a now somewhat complex, multi-drug regimen requiring an injectable-only product has created obstacles to effective and long-lasting treatment.


Editor’s Pick


Tips for Hematology Test Utilization

CLICK HERE to read about Tips for Hematology Test Utilization. Today's clinical hematology laboratory offers a large array of blood product tests contributing to a full service laboratory profile that also includes chemistry, immunology, microbiology, molecular diagnostics, and immunohematology tests. These practice areas comprise more than 4000 different laboratory tests for clinical use, of which, approximately 500 are ordered on a daily basis. An estimated 7 to 10 billion laboratory tests are performed each year in the United States.

Accordingly, test utilization is an ongoing and essential aspect of clinical stewardship. The hematology lab benefits greatly from advanced diagnostic automation, but as with any specialization in the lab, measures must be taken to maximize the utility of laboratory staff and analyzers.


Your Subscription
You are receiving this message as a subscriber to MedicalLab Management. If you would like to unsubscribe from our newsletters, please visit www.medlabmag.com/unsubscribe.

If you are not already a subscriber to MedicalLab Management and would like to subscribe please go to: www.medlabmag.com/subscribe.

Please remember to add us to your address book to ensure that you continue to receive our emails in your inbox.

Sponsorship/Advertising Opportunities
Please contact your account manager at sales@ridgewoodmedia.com or call 201-670-0077, ext. 200.

In the Loop © 2017 Ridgewood Medical Media, LLC. You have permission to forward In the Loop, in its entirety only, provided this copyright notice remains part of your transmission. To subscribe to In the Loop, please send an email to: listmanager@ridgewoodmedia.com and type "Subscribe, (Your email address, and full name)" in the body.

All other rights reserved. None of this material may be reprinted without the express written permission of Ridgewood Medical Media, LLC.
Key Considerations when Purchasing your Ultralow Freezer. Read Online: http://www2.nuaire.com/16241
MedicalLab Management. Your Lab, Under The Microscope. Subscribe Today! http://www.medlabmag.com/subscribe